Literature DB >> 1166890

Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities.

F Deleon-Jones, J W Maas, H Dekirmenjian, J Sanchez.   

Abstract

Previous reports have indicated that some depressed patients excrete less than normal quantities of 3-methoxy-4-hydroxyphenyl glycol (MHPG). The authors present data indicating that a subgroup of depressed patients who excrete less than normal quantities of MHPG may be identified by the application of explicit clinical criteria. They found no significant difference in the excretion of normetanephrine (NM), metanephrine (M), and 3-methoxy-4-hydroxymandelic acid (VMA) among any of the diagnostic subgroups or between each patient group and a healthy comparison group. However, depressed patients diagnosed as having primary affective disorder and bipolar illness excreted significantly less MHPG than did the healthy comparison group.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1166890     DOI: 10.1176/ajp.132.11.1141

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  5 in total

1.  Sulfate and glucuronide conjugates of 3-methoxy-4-hydroxyphenylglycol (MHPG) in urine of depressed patients: central and peripheral influences.

Authors:  L Peyrin; J M Pequignot; G Chauplannaz; B Laurent; G Aimard
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

2.  Course of depressive mood and psychomotor activation in endogenous depression.

Authors:  F Strian; W Albert; C Klicpera
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979

3.  Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline.

Authors:  A F Schatzberg; A H Rosenbaum; P J Orsulak; W A Rohde; T Maruta; E R Kruger; J O Cole; J J Schildkraut
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

4.  Amphetamine withdrawal: effects on threshold of intracranial reinforcement.

Authors:  G Cassens; C Actor; M Kling; J J Schildkraut
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 5.  Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.

Authors:  W Z Potter
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.